Cite
HARVARD Citation
Kleinmann, N. et al. (2020). Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial. Lancet oncology. 21 (6), pp. 776-785. [Online].